全文获取类型
收费全文 | 1559篇 |
免费 | 100篇 |
国内免费 | 54篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 25篇 |
妇产科学 | 9篇 |
基础医学 | 83篇 |
口腔科学 | 105篇 |
临床医学 | 114篇 |
内科学 | 378篇 |
皮肤病学 | 119篇 |
神经病学 | 42篇 |
特种医学 | 24篇 |
外科学 | 112篇 |
综合类 | 150篇 |
预防医学 | 30篇 |
眼科学 | 47篇 |
药学 | 369篇 |
1篇 | |
中国医学 | 66篇 |
肿瘤学 | 26篇 |
出版年
2024年 | 8篇 |
2023年 | 36篇 |
2022年 | 47篇 |
2021年 | 86篇 |
2020年 | 81篇 |
2019年 | 51篇 |
2018年 | 62篇 |
2017年 | 57篇 |
2016年 | 48篇 |
2015年 | 39篇 |
2014年 | 75篇 |
2013年 | 140篇 |
2012年 | 82篇 |
2011年 | 67篇 |
2010年 | 65篇 |
2009年 | 50篇 |
2008年 | 64篇 |
2007年 | 70篇 |
2006年 | 61篇 |
2005年 | 45篇 |
2004年 | 40篇 |
2003年 | 33篇 |
2002年 | 36篇 |
2001年 | 34篇 |
2000年 | 37篇 |
1999年 | 22篇 |
1998年 | 17篇 |
1997年 | 14篇 |
1996年 | 24篇 |
1995年 | 22篇 |
1994年 | 29篇 |
1993年 | 8篇 |
1992年 | 24篇 |
1991年 | 13篇 |
1990年 | 20篇 |
1989年 | 14篇 |
1988年 | 11篇 |
1987年 | 10篇 |
1986年 | 5篇 |
1985年 | 14篇 |
1984年 | 7篇 |
1983年 | 5篇 |
1982年 | 5篇 |
1981年 | 5篇 |
1980年 | 5篇 |
1979年 | 3篇 |
1977年 | 4篇 |
1976年 | 4篇 |
1974年 | 4篇 |
1971年 | 3篇 |
排序方式: 共有1713条查询结果,搜索用时 125 毫秒
1.
2.
Sarah Hallas Andrea Nelson Susan O'Meara Una Adderley Pauline Meskell Jane Nixon Aonghus O'Loughlin Sebastian Probst Wael Tawfick Thomas Wild Georgina Gethin 《Journal of tissue viability》2021,30(3):317-323
BackgroundA venous leg ulcer is a chronic leg wound caused by poor venous blood circulation in the lower limbs. It is a recurring condition causing pain, malodour, reduced mobility, and depression. Randomised controlled trials evaluating treatments for venous leg ulcers provide important evidence to inform clinical decision-making. However, for findings to be useful, outcomes need to be clinically meaningful, consistently reported across trials, and fully reported. Research has identified the large number of outcomes reported in venous leg ulcer trials, impacting both synthesis of results, and clinical decision-making. To address this, a core outcome set will be developed. A core outcome set is an agreed standardised set of outcomes which should be, as a minimum, measured and reported in all trials which evaluate treatment effectiveness for a given indication. A core outcome set has the potential to reduce research waste, improve the utility of RCTs, reduce reporting bias, facilitate treatment comparisons across different sources of evidence and expedite the production of systematic reviews, meta-analyses and evidence-based clinical guidelines.AimThe aim of this project is to develop a core outcome set for research evaluating the effectiveness of interventions for treating venous leg ulceration.MethodsThrough a scoping review of the literature on venous leg ulceration, we will firstly identify a list of candidate outcome domains (broad categories in relation to what is being measured) from randomised controlled trials and qualitative research, and outcomes (specific methods in relation to what is being measured). In two further stages, we will use the resulting lists of outcome domains and outcomes to design two online surveys. A range of stakeholders will be invited to participate in the surveys and they will be asked to indicate which outcome domains and outcomes are most important and should be considered as core in future research reports. 相似文献
3.
4.
5.
C Monteiro B Fernandes J Reis O Tellechea J Freitas A Figueiredo 《Journal of the European Academy of Dermatology and Venereology》2002,16(6):615-617
We report the case of a 75-year-old-woman who presented with bilateral scalp ulcerations and blindness, accompanied by severe headache and scalp tenderness, due to bilateral temporal arteritis without systemic involvement. A biopsy taken from the border of an ulceration showed evidence of giant cell arteritis. She was treated with oral prednisone, 60 mg per day. The ulcerations healed in a few weeks but the vision loss was irreversible. This case highlights for temporal arteritis the importance of accurate and timely diagnosis as well as the need for prompt therapy with systemic steroids in order to avoid major complications, namely loss of vision. It also demonstrates that scalp necrosis and ulcerations are skin signs associated with a poor prognosis. 相似文献
6.
7.
Calciphylaxis – a topical overview 总被引:3,自引:0,他引:3
G Arseculeratne† AT Evans‡ SM Morley† 《Journal of the European Academy of Dermatology and Venereology》2006,20(5):493-502
'Calciphylaxis', a calcification syndrome associated with ischaemic cutaneous necrosis, is acquired naturally in humans in disease states. It is a life and limb-threatening complication, usually observed in patients with renal disease and secondary hyperparathyroidism, but known to occur in the absence of renal or parathyroid disease. The reported mortality rate, which ranges from 60-80%, relates to wound infection, sepsis and organ failure. It is a small-vessel vasculopathy, which is estimated to occur in about 4% of haemodialysis patients. Clinically, violaceous, reticulate areas of cutaneous necrosis and eschar may be evident, particularly in the extremities. In addition to the clinical picture, a raised calcium phosphorous product, an elevated parathyroid hormone level, radiographic evidence of vessel and soft-tissue calcification and the finding of mural calcification affecting small arteries and arterioles on histopathology help to confirm the diagnosis of this entity which generally has a poor prognosis. A high index of suspicion and an active multidisciplinary management approach, with rigorous attention to wound care and prevention of sepsis, are vital in the management of these patients. In this overview, we discuss the pathophysiology, clinical features and associations, risk factors, diagnosis and management issues relating to calciphylaxis. 相似文献
8.
目的研究左旋多巴诱发异动症(levodopa-induced dyskinesias,LID)大鼠纹状体内前强啡肽原(prodynorphin,PDyn)基因表达与DARPP-32蛋白磷酸化状态的变化,探讨LID时直接通路过度活化的机制。方法6-羟多巴胺(6-OHDA)大鼠模型应用左旋多巴治疗28 d诱发LID大鼠模型。采用原位杂交技术检测PDyn mRNA水平,逆转录-聚合酶链反应(RT-PCR)及免疫印迹技术检测LID大鼠纹状体内总DARPP-32的mRNA与蛋白表达及其Thr-34位点磷酸化水平。结果LID大鼠毁损侧PDyn mRNA表达(0.3662±0.0625)较对照组(0.2085±0.0573)及L-dopa治疗组(0.2235±0.0582)明显增高,差异有统计学意义(P<0.01)。LID大鼠毁损侧Thr-34位点磷酸化的DARPP-32蛋白水平(1075.2±103.3)较对照组(198.7±49.5)及L-dopa治疗组(213.9±58.9)明显增高,差异均有统计学意义(P<0.01)。结论DARPP-32蛋白的Thr-34位点的磷酸化水平的改变是LID时多巴胺D1受体介导的直接通路异常活化的关键因素之一。 相似文献
9.
10.
J. A. J. Martyn D. J. Greenblatt J. Hagen D. C. Hoaglin 《European journal of clinical pharmacology》1989,36(4):361-367
Summary We have studied the mechanisms of the increased dosage requirements of the H2-receptor antagonist cimetidine in paediatric burned patients in a pharmacokinetic and pharmacodynamic study.Cimetidine (10–15 mg·kg–1) was given to 21 burned children and multiple blood samples were obtained for determination of plasma cimetidine concentrations and pharmacokinetic analysis.The relation of gastric pH to plasma cimetidine concentrations was studied in five of these children who had nasogastric tubes. In an additional four patients the effects of cimetidine on gastric pH were studied during a continuous infusion of cimetidine, which maintained steady-state plasma cimetidine concentrations above 0.5 µg·ml–1.The mean (SEM) clearance of cimetidine in burned children was 16.22 ml·kg–1 and cimetidine half-life was 1.06 h. The cimetidine clearance and half-life values were significantly higher in burned children compared with our previously reported values for normal adult patients, 8.2 ml·min·kg–1 and 2.21 h respectively.Endogenous creatinine clearance normalized to 70 kg in burned children was 190 ml·min–1. In burned children 41% of the dose of intact cimetidine was excreted during 8 h of the study compared with 45% excretion during 24 h in healthy adult controls previously reported. The correlation coefficient between creatinine and cimetidine clearances was 0.93 (r
2=0.85).The plasma concentration of cimetidine needed to increase gastric pH to 4.0 was 1.0 µg·ml–1, which contrasts with the value of >0.5 µg·ml–1 required for adult burned patients.These findings support the hypothesis that the higher dosage requirements of cimetidine in burned children is due both to enhanced elimination kinetics and to alterations in target organ sensitivity, requiring higher than normal plasma concentrations for the desired effect. In burned children Cimetidine should be given in higher doses and/or more frequently. 相似文献